Merriman Curhan Pounds The Table On Facet Biotechnology (FACT) After Board Formally Rejects Biogen Offer
Go back to Merriman Curhan Pounds The Table On Facet Biotechnology (FACT) After Board Formally Rejects Biogen Offer| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 212.55 +3.40 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $209.15 | 52 Week High | $333.65 | |||
| Open | $211.00 | 52 Week Low | $223.02 | |||
| Day High | $214.07 | P/E | 27.22 | |||
| Day Low | $210.01 | EPS | $7.81 | |||
| Volume | 693,992 | |||||
| FACET BIOTECH (NASDAQ: FACT) | Delayed: 10.68 +0.01 (0.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.67 | 52 Week High | $27.05 | |||
| Open | $10.68 | 52 Week Low | $7.38 | |||
| Day High | $10.68 | P/E | N/A | |||
| Day Low | $10.68 | EPS | $-5.90 | |||
| Volume | 32,597 | |||||
